Posted by Michael Wonder on 14 May 2025
Lilly Canada announces availability of Mounjaro KwikPen (tirzepatide) in all doses, advancing care for adults living with type 2 diabetes
13 May 2025 - The multi-dose, single-patient-use, pre-filled pen allows for personalised treatment plans that can cater to individual patient needs.
Lilly Canada is pleased to announce that Mounjaro KwikPen (tirzepatide injection) is now available in Canada in all doses, offering a convenient treatment option for adults with type 2 diabetes.
